DrugRepV_0863 | Tretinoin | Dermatologicals; Antineoplastic and Immunomodulating Agents | Acne | Photodamaged skin | Keratinization disorders such as ichthyosis and keratosis follicularis | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (57.47 %) | Approved | 27476412 |
DrugRepV_2535 | FK-506 | Dermatologicals; Antineoplastic and Immunomodulating Agents | Liver transplantation | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-0.6057741 %) | Approved | 27742486 |
DrugRepV_2544 | Tretinoin | Dermatologicals; Antineoplastic and Immunomodulating Agents | Acne | Photodamaged skin | Keratinization disorders such as ichthyosis and keratosis follicularis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-0.7746726 %) | Approved | 27742486 |
DrugRepV_5578 | FK-506 | Dermatologicals; Antineoplastic and Immunomodulating Agents | Liver transplantation | SARS Coronavirus-2 | 2019-nCoV/USA-WA1/2020 | NA | NA | Decrease (50 %) | Approved | 32353859 |